is a rare form of non-Hodgkin's lymphoma.
Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia
and related lymphoid neoplasms.
Alexanian et al., "Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia
: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia
," Seminars in Oncology, vol.
In 2007, I was diagnosed with a rare and incurable form of blood cancer called Waldenstrom's Macroglobulinemia
which affects roughly 1,500 in the U.S.
We did a review of major clinical trials of bortezomib in patients with multiple myeloma, Waldenstrom's macroglobulinemia
and plasma cell leukaemia (Table 2) to investigate the incidence of congestive cardiac failure reported after administration of bortezomib.
Besides PEO, DCS has also been observed in angio-immunoblastic lymphoma, (2) cutaneous Waldenstrom's macroglobulinemia
, (3) acanthosis nigricans, (1,4) erysipelas, discoid lupus and acute contact dermatitis.
announced that the FDA granted Breakthrough Therapy Designation to the investigational oral agent ibrutinib monotherapy for the treatment of patients with relapsed or refractory mantle cell lymphoma and to ibrutinib monotherapy for the treatment of patients with Waldenstrom's macroglobulinemia
, both of which are B-cell malignancies.
Five years on he was so weakened by the rare condition, Waldenstrom's macroglobulinemia
, that he felt on the verge of death.
Plasma cell dyscrasias and Waldenstrom's macroglobulinemia
. In: Manual of Clinical Oncology.
Berenson, J.R, & Casciato, D.A, (2009) Plasma Cell Dyscrasias and Waldenstrom's Macroglobulinemia
, in Manual of Clinical Oncology, J.W Pine ed) Lippincott Williams & Wilkins, Philadelphia